IM Cannabis Registers 25.3M Resale Shares — ~1,375% of Its 1.84M Outstanding
IMCC is trading near its 52-week low of $0.581 (1.6% above the low).
Summary
IM Cannabis registered 25.3 million shares for resale by L.I.A. Pure Capital — about 1,375% of its 1.84 million shares outstanding — tied to the US$1.2 million convertible note it closed on November 4. The company receives no proceeds from the resale.
Key Events · Financing and Capital Events · IMCC
-
25.3M Resale Shares Registered
The F-3 covers up to 25,348,613 common shares: 8,780,892 issuable on conversion of the Initial Promissory Note and 16,567,721 issuable on exercise of the accompanying warrant.
-
Dilution of ~1,375% of Outstanding
Against 1,844,162 shares outstanding, full conversion and exercise would take the count to 27,192,775 — an increase of approximately 1,375%, per the filing's own risk factor.
-
Conversion Priced at Deep Discount
The note converts at the lower of US$0.610 or 85% of the 20-day VWAP, floored at US$0.1449 — well below the US$0.6265 last reported sale price on November 9, 2026.
-
Warrant Ratchet Adds Future Dilution
The warrant's US$0.610 exercise price resets to the higher of a new lower issuance price or the US$0.1449 floor, so later discounted raises expand the share count again.
Analysis · IMCC · Life Sciences
This F-3 makes the November 4 convertible note tradable, and the size is the story: 25,348,613 shares registered for resale against just 1,844,162 shares outstanding. The note converts at the lower of US$0.610 or 85% of the 20-day VWAP, floored at US$0.1449 — a 77% discount to the US$0.6265 last sale on November 9 — so the holder is incentivized to convert and sell into any strength. The warrant adds a ratchet that resets its US$0.610 strike down to the higher of a new lower issuance price or the floor, meaning future discounted raises mechanically expand the share count again. The company nets nothing from the resale; it already booked US$1,020,000 on the note. With the stock at $0.59 near its 52-week low and a going-concern history, this is a structural overhang that caps rallies rather than a one-time dilution event.
How filings like this one have moved
In the 30 days to Nov 11, 2026, 48.1% of the 1752 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IMCC was trading at $0.59 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1M. The 52-week trading range was $0.58 to $62.40. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.